Pegaptanib
- Level
- Commodity
- Parent
- 51241100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51241122This classification denotes an angiogenesis inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H1PA8H1EN. European Medicines Agency schedules Pegaptanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25196. Pegaptanib generally arises in the molecular formula C15H28N3O6(C2H4O)N(C2H4O)N. The term PEGAPTANIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule pegaptanib under HS 39072021 and SITC 57419. As of Q4 2014, PEGAPTANIB remains the US FDA Preferred Term for this commodity. Pegaptanib bears US NLM identifiers UMLS ID C1531015 and NCI Concept Code C90657. SMILES: COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC.
Same parent
Under 51241100 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51240000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.